John Riddell

A comprehensive account of the rise and fall of the Communist International, from its founding by Lenin after the Russian Revolution to its eventual collapse under Stalinism. The Communist International (or ‘Comintern’) was launched in 1919 to promote worldwide extension of the 1917 workers’ and peasants’ revolution in Russia. During the Comintern’s first years under the leadership of V.I. Lenin, it proposed and tested strategic and tactical concepts that retain their value and continue to be studied. While the Communist International was soon to be deformed and destroyed by the rise of bureaucracy and authoritarianism associated with Stalinism, its perspective on the fight for international revolutionary change still presents a compelling vision, and is an inspiring example for millions throughout the world.

The Communist International (or ‘Comintern’) was launched in 1919 to promote worldwide extension of the 1917 workers’ and peasants’ revolution in Russia. During the Comintern’s first years under the leadership of V.I. Lenin, it proposed and tested strategic and tactical concepts that retain their value and continue to be studied. While the Communist International was soon to be deformed and destroyed by the rise of bureaucracy and authoritarianism associated with Stalinism, its perspective on the fight for international revolutionary change still presents a compelling vision, and is an inspiring example for millions throughout the world.

The Pharmaceutical Industry has been undergoing a major transformation since the heady days of 'big pharma' in the 1970s and 80s. Patent expiry, the rise of generics, and the decline of the blockbuster drug have all changed the landscape over the last 10-15 years. It's an environment where products can take 10 years or more to come to market, billions are spent on research and development, jobs are being shed in the western pharma homelands and regulators and the public are more demanding than ever. So what part is Knowledge Management playing and going to play in this vital international industry? Knowledge Management (KM) has many facets from providing comprehensive knowledge bases for workers, through the sharing of advice and problem solving, to providing an environment for innovation and change. This book, focusing on research and development, and manufacturing-based companies, explores how a range of techniques and approaches have been applied in the unique environment of the Pharmaceutical Industry, and examine how it can help the industry in the 21st century. Whilst the book is centered on the Pharmaceutical Industry, its objective will be to discuss and demonstrate how Knowledge Management can be applied in a variety of environments, and with a range of cultural issues. KM practitioners, and potential practitioners, both within and outside the Pharmaceutical Industry, will be able to gain valuable guidance and advice from both the examples of good practice and the lessons learned by the authors and contributors.

The Salt-Foot Controversy, As It Appeared In Blackwood'S Magazine; To Which Is Added A Reply To The Article Published In No. Xviii. Of That Work; With Other Extracts, And An Appendix, Containing Some Remarks On The Present State Of The Lyon Office has been considered by academicians and scholars of great significance and value to literature. This forms a part of the knowledge base for future generations. So that the book is never forgotten we have represented this book in a print format as the same form as it was originally first published. Hence any marks or annotations seen are left intentionally to preserve its true nature.

Vindication Of The "Clanronald Of Glengary" Against The Attacks Made Upon Them In The Inverness Journal And Some Recent Printed Performances: With Remarks As To The Descent Of The Family Who Style Themselves "Of Clanronald" 1821 has been considered by academicians and scholars of great significance and value to literature. This forms a part of the knowledge base for future generations. So that the book is never forgotten we have represented this book in a print format as the same form as it was originally first published. Hence any marks or annotations seen are left intentionally to preserve its true nature.

Comments in Refutation of Pretensions Advanced for the First Time and Statements in a Recent Work is an unchanged, high-quality reprint of the original edition of 1860. Hansebooks is editor of the literature on different topic areas such as research and science, travel and expeditions, cooking and nutrition, medicine, and other genres. As a publisher we focus on the preservation of historical literature. Many works of historical writers and scientists are available today as antiques only. Hansebooks newly publishes these books and contributes to the preservation of literature which has become rare and historical knowledge for the future.

Mitre Court - A tale of the great city is an unchanged, high-quality reprint of the original edition of 1885. Hansebooks is editor of the literature on different topic areas such as research and science, travel and expeditions, cooking and nutrition, medicine, and other genres. As a publisher we focus on the preservation of historical literature. Many works of historical writers and scientists are available today as antiques only. Hansebooks newly publishes these books and contributes to the preservation of literature which has become rare and historical knowledge for the future.

Mitre Court - A tale of the great city is an unchanged, high-quality reprint of the original edition of 1885. Hansebooks is editor of the literature on different topic areas such as research and science, travel and expeditions, cooking and nutrition, medicine, and other genres. As a publisher we focus on the preservation of historical literature. Many works of historical writers and scientists are available today as antiques only. Hansebooks newly publishes these books and contributes to the preservation of literature which has become rare and historical knowledge for the future.

The Pharmaceutical Industry has been undergoing a major transformation since the heady days of 'big pharma' in the 1970s and 80s. Patent expiry, the rise of generics, and the decline of the blockbuster drug have all changed the landscape over the last 10-15 years. It's an environment where products can take 10 years or more to come to market, billions are spent on research and development, jobs are being shed in the western pharma homelands and regulators and the public are more demanding than ever. So what part is Knowledge Management playing and going to play in this vital international industry? Knowledge Management (KM) has many facets from providing comprehensive knowledge bases for workers, through the sharing of advice and problem solving, to providing an environment for innovation and change. This book, focusing on research and development, and manufacturing-based companies, explores how a range of techniques and approaches have been applied in the unique environment of the Pharmaceutical Industry, and examine how it can help the industry in the 21st century. Whilst the book is centered on the Pharmaceutical Industry, its objective will be to discuss and demonstrate how Knowledge Management can be applied in a variety of environments, and with a range of cultural issues. KM practitioners, and potential practitioners, both within and outside the Pharmaceutical Industry, will be able to gain valuable guidance and advice from both the examples of good practice and the lessons learned by the authors and contributors.